Delivery Order SPE2DB20D1004-SPE2DB25FNJTA
- Not listed
- The Defense Logistics Agency awarded a $2,095.80 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The vaccine will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rabavert rabies vaccine with diluents, valued at $18,968.07. This firm fixed-price delivery order, which is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), represents a non-competitive set-aside procurement. The order will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $40,441.62 for Rabavert rabies vaccine with diluents under a firm fixed-price contract. This non-set-aside award, issued on July 29, 2025, represents a child order against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The vaccine will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date...
- The Defense Logistics Agency awarded a $2,095.80 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Rabavert rabies vaccine with diluents. The contract is non-set-aside and competitively awarded, with an ultimate completion date of July 28, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,519.20 for Rabavert rabies vaccine with diluents on July 24, 2025, with an ultimate completion date of July 25, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price transaction for pharmaceutical supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,257.48 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents, with an ultimate completion date of August 11, 2025. This is a firm fixed-price, non-set-aside contract for delivery to AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting the federal government's medical supply needs through AmerisourceBergen's established vendor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents under a firm fixed-price contract valued at $18,728.13. The order, issued on July 29, 2025, with an ultimate completion date of July 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $13,409.25 to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price delivery order, issued on July 21, 2025, represents a competitively awarded contract with no set-aside designation and an ultimate completion date of July 22, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $26,596.25 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents. This firm fixed-price contract, effective July 25, 2025, with ultimate completion by July 28, 2025, represents a small-value pharmaceutical procurement from the prime contractor's place of business in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's established capability...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.22 to AmerisourceBergen Drug Corp for the supply of Rabavert rabies vaccine with diluents. The contract, issued on July 20, 2025, with an ultimate completion date of July 21, 2025, utilizes firm fixed pricing with no set-aside designation, indicating competitive award. The product will be delivered to the vendor's corporate office location in Conshohocken, Pennsylvania, supporting the agency's medical supply chain...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25FNJTADelivery Order
The Defense Logistics Agency awarded a $2,816.02 delivery order to AmerisourceBergen Drug Corp for Rabavert rabies vaccine with diluents on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and carries no set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle providing a wide range of drugs, vaccines, and medical supplies to military healthcare systems globally. AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, regularly fulfills delivery orders through this contract vehicle to support Defense Health Agency operations and other government healthcare systems with both brand-name and generic medications across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 7/30/25 |